José Ramón
Azanza Perea
Researcher to 2020
Publications (224) José Ramón Azanza Perea publications
2024
-
Fármacos antifúngicos
Castells Hernández farmacología en enfermería (Elsevier), pp. 592-604
-
Fármacos antivirales
Castells Hernández farmacología en enfermería (Elsevier), pp. 605-620
2021
-
Liposomal amphotericin B: Clinical pharmacology, pharmacokinetics and pharmacodynamics
Revista Iberoamericana de Micologia
-
Recommendations for antibiotic selection for severe nosocomial infections
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 34, Núm. 5, pp. 511-524
-
The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain
Mycoses, Vol. 64, Núm. 1, pp. 66-77
2020
-
Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study
European Journal of Drug Metabolism and Pharmacokinetics, Vol. 45, Núm. 2, pp. 265-272
-
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 174-181
-
Single-Institution Experience in Clinical Trials during the COVID-19 Pandemic in Spain: Not So Bad after All?
JCO Global Oncology
-
The sars-cov-2 ivermectin navarra-isglobal trial (saint) to evaluate the potential of ivermectin to reduce covid-19 transmission in low risk, non-severe covid-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
Trials, Vol. 21, Núm. 1
2019
-
Ceftobiprole: pharmacokinetics and PK/PD profile
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 32, pp. 11-16
-
La «siemprefiesta»
Et nunc et semper festa (EUNSA. Ediciones Universidad de Navarra, S.A.), pp. 9-12
-
The pharmacodynamic bases of the prescription of antimicrobials
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 32, pp. 35-37
2018
-
Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy
Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100
-
Antibióticos B-lactámicos
Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 729-750
-
Antibióticos aminoglucósidos, tetraciclinas, rigeciclina y cloranfenicol
Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 751-770
-
Antibióticos macrólidos y otros antibióticos
Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 771-788
-
Antibióticos. Generalidades
Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 715-728
-
Pharmacological profile of isavuconazole
Revista Iberoamericana de Micologia
2017
-
Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in spain
ClinicoEconomics and Outcomes Research, Vol. 9, pp. 39-47
-
Dalbavancina: parámetros farmacocinéticos y farmacodinámicos
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, pp. 22-27